abstract |
The present invention relates to the use of vascular endothelial-protein tyrosine phosphatase (VE-PTP), a nucleic acid molecule coding therefor or an effector of the polypeptide or the nucleic acid molecule for the manufacture of an agent for monitoring or modulating VE-cadherin mediated processes or disorders. |